164 related articles for article (PubMed ID: 25739938)
1. A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
Kim SM; Lee ST; Ryu KJ; Kim HJ; Kim SH; Ko YH; Kim WS; Kim SJ
Leuk Lymphoma; 2015; 56(11):3052-7. PubMed ID: 25739938
[TBL] [Abstract][Full Text] [Related]
2. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma.
Jung HJ; Chen Z; McCarty N
Leuk Lymphoma; 2011 Jun; 52(6):1066-79. PubMed ID: 21599592
[TBL] [Abstract][Full Text] [Related]
3. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
Ondrejka SL; Lai R; Smith SD; Hsi ED
Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric identification of candidate normal stem cell populations in CD45-negative B-cell precursor acute lymphoblastic leukaemia.
Vormoor J; Baersch G; Baumann M; Ritter J; Jürgens H
Br J Haematol; 1998 Mar; 100(3):501-8. PubMed ID: 9504632
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Prospective isolation of clonogenic mantle cell lymphoma-initiating cells.
Chen Z; Ayala P; Wang M; Fayad L; Katz RL; Romaguera J; Caraway N; Neelapu SS; Kwak LW; Simmons PJ; McCarty N
Stem Cell Res; 2010 Nov; 5(3):212-25. PubMed ID: 20851072
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma-management in evolution.
Rajguru S; Kahl BS
Chin Clin Oncol; 2015 Mar; 4(1):8. PubMed ID: 25841715
[TBL] [Abstract][Full Text] [Related]
8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma.
Kim B; Lee ST; Kim HJ; Kim SH
Ann Lab Med; 2015 Mar; 35(2):187-93. PubMed ID: 25729719
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of CD19 positive cell counts in bone marrow with therapeutic efficacy in patients with multiple myeloma].
Zhang L; Zhou ZH; Li XY; Ouyang J; Su C; Li J; Luo SK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):64-7. PubMed ID: 21362223
[TBL] [Abstract][Full Text] [Related]
11. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
13. Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.
Medina DJ; Abass-Shereef J; Walton K; Goodell L; Aviv H; Strair RK; Budak-Alpdogan T
PLoS One; 2014; 9(4):e91042. PubMed ID: 24722054
[TBL] [Abstract][Full Text] [Related]
14. [Mantle cell lymphoma diagnosis].
Choukri M; Taheri H; Seddik R; Benkirane S; Hamama A; Masrar A; Agoumi NB; Chabraoui L
Ann Biol Clin (Paris); 2013; 71(1):107-12. PubMed ID: 23396434
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature.
Pawarode A; Baer MR; Padmanabhan S; Wallace PK; Barcos M; Sait SN; Block AW; Wetzler M; Battiwalla M
Leuk Lymphoma; 2005 Dec; 46(12):1813-8. PubMed ID: 16263586
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of flow cytometric immunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy.
Liu W; Medeiros LJ; Lin P; Romaguera JE; Wang SA; Jorgensen JL
Am J Clin Pathol; 2012 Apr; 137(4):634-40. PubMed ID: 22431541
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
19. Biology and management of mantle cell lymphoma.
Leonard JP; Schattner EJ; Coleman M
Curr Opin Oncol; 2001 Sep; 13(5):342-7. PubMed ID: 11555710
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]